8-K: ProAssurance Completes Merger with The Doctors Company

ProAssurance Corporation has finalized its merger with The Doctors Company, resulting in its transition to a wholly owned subsidiary and subsequent delisting from the NYSE.

Summary

• ProAssurance Corporation completed its merger with The Doctors Company on June 26, 2026.
• ProAssurance shareholders received $25.00 per share in cash for each share of common stock.
• All outstanding restricted stock units, performance shares, and deferred compensation shares were converted into the right to receive the $25.00 per share cash consideration.
• The company has terminated its Second Amended and Restated Credit Agreement, repaying all outstanding obligations.
• ProAssurance has requested the delisting of its common stock from the New York Stock Exchange and intends to terminate its SEC reporting obligations.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents the expected conclusion of a previously announced merger agreement rather than a new operational development.

Positives

• Shareholders received a definitive cash exit at $25.00 per share.
• Successful completion of the merger agreement originally announced in March 2025.
• Full repayment of all outstanding credit facility obligations, strengthening the balance sheet of the surviving entity.

Negatives

• Public shareholders no longer have an equity interest in the company.
• The company will cease to be a publicly traded entity, reducing transparency for external market participants.
• Termination of SEC reporting obligations limits future public disclosure of financial performance.

Risks

• Integration risks associated with becoming a wholly owned subsidiary of The Doctors Company.
• Potential for business disruption during the transition period.
• Loss of key personnel during the post-merger integration phase.

Future Outlook

The company is now a wholly owned subsidiary of The Doctors Company and will no longer provide public financial guidance or periodic SEC reports.

Management Comments

• The board of directors and officers of ProAssurance were replaced by appointees of The Doctors Company upon the effective time of the merger.

Industry Context

StockSavvy.ai notes that this transaction represents a continued consolidation trend within the medical professional liability insurance sector, as smaller or mid-sized players seek scale through integration with larger reciprocal exchanges.

Comparison to Industry Standards

• The $25.00 per share cash consideration represents a standard exit strategy for public insurance entities in take-private transactions.
• The transition to a wholly owned subsidiary of a reciprocal inter-insurance exchange is consistent with recent structural shifts in the U.S. insurance market.

Management Changes

Corporate Governance

Legal Proceedings

• None disclosed in this filing.

Related Party Transactions

• None disclosed in this filing.

Stakeholder Impact

• Shareholders receive cash liquidity for their holdings.
• Employees and customers transition to a new parent company structure.
• Creditors have been satisfied through the repayment of the Credit Agreement.

Next Steps

• File Form 25 with the SEC to delist from the NYSE.
• File Form 15 with the SEC to terminate registration and reporting obligations.
• Integration of operations into The Doctors Company.

Key Dates

Keywords

Merger, Acquisition, ProAssurance, The Doctors Company, Delisting, Insurance, Take-private